A unique equity portfolio
based on fundamental research
About
Night Watch Investment Management is an alternative asset manager focused on global equities, selected based on our in-depth proprietary research. Our investment style is best described as value plus catalyst. We invest in companies that have strong free cash flow generation and a favorable valuation. However, cheap stocks can be cheap forever, so we look for an identifiable near-term catalyst to unlock this value. Finally, we prefer to invest alongside management and actively engage with businesses to drive decisions toward shareholder interests.
NWIM was founded by Roderick van Zuylen and Eileen Ke, to create an investment product that provides exposure to high conviction and likely unique names, backed by strong fundamentals. Our team brings over two decades of institutional portfolio management experience at multi-billion dollar global asset managers, building on an audited track record of outperformance.
Our investment philosophy
VALUE
Cash flow generation drives the intrinsic value of a business. Two important factors we look for are Free Cash Flow yield and Free Cash Flow growth.
CATALYST
Cheap stocks can be cheap forever. Therefore we look for companies that benefit from improving business fundamentals such as macro tailwinds, cycle inflections, and/or company transformations.
INSIDE OWNERSHIP
Strong management ownership ensures alignment of interests between company management and investors.
Co-investing with management also offers downside protection.
Team
Roderick van Zuylen, CFA
Co-founder and
Chief Investment Officer
Investment experience since 2011 with audited track records of outperformance
Senior Portfolio Manager at Kempen Capital Management (2021-2023)
Head of Research / Portfolio Manager at Laaken Asset Management (2015-2021)
MS Engineering, CFA Charterholder
Eileen Ke, MBA
Co-founder and
Chief Operating Officer
Experience in marketing, operations, strategy, and finance leadership roles across start-up and multi billion dollar companies
Chief Commercial Officer at Edge Medical Ventures and advisor to start-ups on commercialization and product launch
MS Finance, MBA
Martijn Kleinbussink
Research Consultant
Senior Portfolio Manager at Kempen Capital Management (2017-2023)
Equities Analyst at IBS Capital Management (2014-2017)
MS Finance
